A radiology journal has published an addendum to a 2005 review on cancer imaging techniques, alerting readers to figure duplication.
But that’s not what caught our attention about this case. The addendum, published in January, is the third notice that The British Journal of Radiology (BJR) has issued for the 2005 review by Hedvig Hricak, chair of the Department of Radiology at Memorial Sloan Kettering in New York City. The notices, published between 2014 and 2018, all describe duplication.
Why the series of notices, all describing a similar problem?
Kevin Prise, one of the journal’s editors-in-chief, told Retraction Watch that a reader had contacted the journal about the 2005 review on three different occasions over the years, “which resulted in three investigations, all following COPE guidelines:”
Retraction was considered as part of the investigations, but was not deemed appropriate in response to any of the comments.
We were also notified of the latest notice by a reader who declined to identify themselves, but forwarded communications with the journal about this paper.
The first notice, published in 2014, describes “overlap” between the 2005 review, “MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer,” and a 2004 review in RadioGraphics, on which Hricak is second author.
The next two notices, published in 2016 and in 2018, explain that Figure 4 was published in two other articles—a 2005 research paper in Radiology and a 2006 review in Abdominal Imaging, which was retracted in 2015 because it contained “similar text and illustrations to previously published articles.”
Hricak did not respond to our request for comment.
Prise provided more details about why a retraction “was not deemed appropriate” in each instance of overlap. For the 2014 addendum, Prise told us:
During the investigation it was acknowledged that there was some overlap in content, but that the two papers were written for different audiences and drew different conclusions. It was concluded that both reviews had their place in the literature and it was not appropriate to retract. In the spirit of clarity and openness, we agreed to publish a short addendum to alert readers to the other review in Radiographics.
For the 2016 correction, Prise said the journal contacted Radiology about the duplicated figure and:
… confirmed that a formal permission request was not required because there was a common author to both papers. It was concluded that there was no intention to mislead as the paper in question appeared in the citation list.
The most recent notice for the 2005 review highlights the duplication of Figure 4 and explains that “the clinical staging recorded in the figure captions in the two papers differ.” When we asked Prise about the discrepancy, he noted:
The important matter for the learning point is that the author clearly states in the figure legend that the final pathological staging was Gleason grade 3+3, pT2b.
The review has been cited 83 times, according to Clarivate Analytics’ Web of Science—technically a “highly cited paper,” meaning it ranked in the top 1 percent of all papers in its field for the year it was published.
This is not the first time editors have opted not to retract an allegedly redundant paper on which Hricak was a co-author. In 2016, the editors of Abdominal Imaging and Annals of Surgical Oncology wrote a commentary explaining why they believed two of her papers—on which she was a middle author—were sufficiently unique, despite an overlap in the patient cohort.
Prise told us:
We acknowledge that it is unusual for there to be three separate addendum/erratum notices on a single paper. We wanted to ensure that readers are fully aware of any issues that have arisen which may inhibit their understanding of the work presented.
Like Retraction Watch? You can make a tax-deductible contribution to support our growth, follow us on Twitter, like us on Facebook, add us to your RSS reader, sign up for an email every time there’s a new post (look for the “follow” button at the lower right part of your screen), or subscribe to our daily digest. If you find a retraction that’s not in our database, you can let us know here. For comments or feedback, email us at email@example.com.